Skip to main content

Advertisement

SpringerLink
Log in

Recurrent respiratory papillomatosis: an overview

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Recurrent respiratory papillomatosis (RRP) primarily caused by human papillomas virus is a rare and benign neoplasm, primarily involving the epithelium mucosae of the respiratory tract. RRP may occur anywhere in the respiratory tract with a predilection to the laryngeal area and may potentially threaten life. Because of the absence of specific clinical manifestations, the diagnosis of this disease is easily delayed. The high awareness of RRP and performing endoscopy as soon as possible in suspected patients are the prerequisites for early diagnosis. Surgical removal on endoscope is still a fundamental treatment. Adjuvant treatment is required only in some patients. Because of the potential of malignant transformation and recurrence, careful follow-up for RRP is required for early detection and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chhetri DK, Shapiro NL (2003) A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 129:1081–1085

    Article  PubMed  Google Scholar 

  2. Bishai D, Kashima H, Shah K (2000) The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126:935–939

    CAS  PubMed  Google Scholar 

  3. Steinbrook R (2006) The potential of human papillomavirus vaccines. N Engl J Med 354:1109–1112

    Article  CAS  PubMed  Google Scholar 

  4. Ribeiro KM, Alvez JM, Pignatari SS et al (2006) Detection of human papilloma virus in the tonsils of children undergoing tonsillectomy. Braz J Infect Dis 10:165–168

    Article  PubMed  Google Scholar 

  5. Gissmann L, Wolnik L, Ikenberg H et al (1983) Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80:560–563

    Article  CAS  PubMed  Google Scholar 

  6. Silverberg MJ, Thorsen P, Lindeberg H et al (2003) Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101:645–652

    Article  PubMed  Google Scholar 

  7. Kashima HK, Shah F, Lyles A et al (1992) A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102:9–13

    CAS  PubMed  Google Scholar 

  8. Pignatari SS, Liriano RY, Avelino MA et al (2007) Gastroesophageal reflux in patients with recurrent laryngeal papillomatosis. Braz J Otorhinolaryngol 73:210–214

    PubMed  Google Scholar 

  9. Tabrizi SN, Garland SM (1996) Is cryotherapy treating or infecting? Med J Aust 164:263

    CAS  PubMed  Google Scholar 

  10. Garden JM, O’Banion MK, Bakus AD et al (2002) Viral disease transmitted by laser-generated plume (aerosol). Arch Dermatol 138:1303–1307

    Article  PubMed  Google Scholar 

  11. Carvalho CM, Huot L, Charlois AL et al (2009) Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol 129:462–470

    Article  PubMed  Google Scholar 

  12. Soldatski IL, Onufrieva EK, Steklov AM et al (2005) Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope 115:1848–1854

    Article  PubMed  Google Scholar 

  13. Shibuya H, Kutomi T, Kujime K et al (2008) An adult case of multiple squamous papillomas of the trachea associated with human papilloma virus type 6. Inter Med 47:1535–1538

    Article  Google Scholar 

  14. DeVoti JA, Rosenthal DW, Wu R et al (2008) Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med 14:608–617

    Article  CAS  PubMed  Google Scholar 

  15. Wu R, Abramson AL, Shikowitz MJ et al (2005) Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res 11(17):6155–6161

    Article  CAS  PubMed  Google Scholar 

  16. Scurry WC Jr, McGinn JD (2008) Recurrent respiratory papillomatosis in pregnancy: a case of emergent airway management. Ear Nose Throat J 87:E8–E11

    PubMed  Google Scholar 

  17. Rady PL, Schnadig VJ, Weiss RL et al (1998) Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108:735–740

    Article  CAS  PubMed  Google Scholar 

  18. Gerein V, Rastorguev E, Gerein J et al (2004) 2′, 5′-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis. J Laryngol Otol 118:750–756

    Article  CAS  PubMed  Google Scholar 

  19. Blumin JH, Handler EB, Simpson CB et al (2009) Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol 118:481–485

    PubMed  Google Scholar 

  20. Lee LA, Cheng AJ, Fang TJ et al (2008) High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118:50–55

    Article  PubMed  Google Scholar 

  21. Leman JA, Benton EC (2000) Verrucas. Guidelines for management. Am J Clin Dermatol 1:143–149

    Article  CAS  PubMed  Google Scholar 

  22. Pignatari S, Smith EM, Gray SD et al (1992) Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol 101:408–412

    CAS  PubMed  Google Scholar 

  23. Fox PA, Tung MY (2005) Human papillomavirus: burden of illness and treatment cost considerations. Am J Clin Dermatol 6:365–381

    Article  PubMed  Google Scholar 

  24. Perkins JA, Inglis AF Jr, Richardson MA (1998) Iatrogenic airway stenosis with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 124:281–287

    CAS  PubMed  Google Scholar 

  25. Ulualp SO, Ryan MW, Wright ST (2007) Microdebrider removal of tracheal papilloma via tracheostomy in the child with an obliterated larynx. J Laryngol Otol 121:1070–1072

    Article  CAS  PubMed  Google Scholar 

  26. Thorne MC, Zur KB (2009) Transoral trans-stomal microdebrider excision of tracheal papillomatosis. Laryngoscope 119:964–966

    Article  PubMed  Google Scholar 

  27. Derkay CS (1995) Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 121:1386–1391

    CAS  PubMed  Google Scholar 

  28. Kimberlin DW (2004) Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 63:141–151

    CAS  PubMed  Google Scholar 

  29. Bielecki I, Mniszek J, Cofała M (2009) Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol 73:681–684

    Article  PubMed  Google Scholar 

  30. Donne AJ, Rothera MP, Homer JJ (2008) Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 72:939–944

    Article  CAS  PubMed  Google Scholar 

  31. McMurray JS, Connor N, Ford CN (2008) Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Ann Otol Rhinol Laryngol 117:477–483

    PubMed  Google Scholar 

  32. Broekema FI, Dikkers FG (2008) Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 265:871–879

    Article  PubMed  Google Scholar 

  33. Lott DG, Krakovitz PR (2009) Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis. Laryngoscope 119:567–570

    Article  CAS  PubMed  Google Scholar 

  34. Kashima H, Leventhal B, Clark K et al (1988) Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions. Laryngoscope 98:334–340

    CAS  PubMed  Google Scholar 

  35. Gerein V, Rastorguev E, Gerein J et al (2005) Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol 114:463–471

    PubMed  Google Scholar 

  36. Villa LL, Costa RL, Petta CA et al (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271–278

    Article  PubMed  Google Scholar 

  37. Govan VA (2008) A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil). Ther Clin Risk Manag 4:65–70

    CAS  PubMed  Google Scholar 

  38. Freed GL, Derkay CS (2006) Prevention of recurrent respiratory papillomatosis: role of HPV vaccination. Int J Pediatr Otorhinolaryngol 70:1799–1803

    Article  PubMed  Google Scholar 

  39. Chesson HW, Forhan SE, Gottlieb SL et al (2008) The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 26:4513–4518

    Article  PubMed  Google Scholar 

  40. Vandepapeliere P, Barrasso R, Meijer CJ et al (2005) Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis 192:2099–2107

    Article  CAS  PubMed  Google Scholar 

  41. Giuliano AR, Tortolero-Luna G, Ferrer E et al (2008) Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26(Suppl 10):K17–K28

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Respiratory Diseases Department of the Chinese PLA General Hospital, 28 Fuxing Rd, Beijing, 100853, China

    Qingliang Xue & Jianxin Wang

  2. The Third Hospital of the General Brigade of Armed Police, Beijing, China

    Haitao Wang

Authors
  1. Qingliang Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haitao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianxin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianxin Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xue, Q., Wang, H. & Wang, J. Recurrent respiratory papillomatosis: an overview. Eur J Clin Microbiol Infect Dis 29, 1051–1054 (2010). https://doi.org/10.1007/s10096-010-0963-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-010-0963-6

Keywords

Search

Navigation